Our Mission


Founded in December 2013, Adjuvatis is specialized in the development, manufacturing and formulation of biodegradable particles, called i-Particles®. Developed by Dr Bernard Verrier and his CNRS team at the Institute of Biology and Chemistry Proteins (www.ibcp.fr ) this innovative technology has multiple applications. Our company’s key objective is to share the i-Particles® platform and help biopharmaceutical & diagnostic companies in:

  • the generation of new antibodies (polyclonal and monoclonal) using hard to use antigens formulated on our particles
  • the development of new adjuvants for safer and more efficient vaccines (animal & human vaccines)
  • offering new protein delivery solutions

Our laboratories are located in Lyon Gerland, one of the largest biotech hubs in France, close to Sanofi Pasteur, Merial or ENS Lyon.

The combination of safe-by-design and sustainable development concepts
i-Particles® are made from a biocompatible and biodegradable polymer. With sizes ranging from 150 nm to 300 nm, these particles are synthesized at Adjuvatis following a robust and eco-friendly process.

Highly versatile technology
i-Particles® have shown important adjuvant properties by eliciting a strong and specific immune response when formulated with several types of proteins.
Thanks to their protective properties, they enable to lower the antigen amount by 10 to 100 times, offering a potential alternative to the controversial mineral salt-based adjuvants.